Helix BioPharma Corp
(OTCPK:HBPCF)
$0.145
0[0.00%]
Last update: 9:32AM (Delayed 15-Minutes)
Get Real Time Here
Open-Close-
Vol / Avg.0 / 1.000KMkt Cap31.418M
Day Range- - -52 Wk Range0.145 - 0.160

Helix BioPharma Stock (OTC:HBPCF), Key Statistics

Helix BioPharma Stock (OTC: HBPCF) analysis, key statistics.

Valuation Measures
Enterprise Value
38M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
674K
Total Assets
1.6M
Total Liabilities
674K
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -

Helix BioPharma Stock (OTC:HBPCF), Key Statistics

Helix BioPharma Stock (OTC: HBPCF) analysis, key statistics.

Valuation Measures
Enterprise Value
38M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
674K
Total Assets
1.6M
Total Liabilities
674K
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -

Helix BioPharma Stock (OTC:HBPCF), Key Statistics

Helix BioPharma Stock (OTC: HBPCF) analysis, key statistics.

Valuation Measures
Enterprise Value
38M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
674K
Total Assets
1.6M
Total Liabilities
674K
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -

Helix BioPharma Stock (OTC:HBPCF), Key Statistics

Helix BioPharma Stock (OTC: HBPCF) analysis, key statistics.

Valuation Measures
Enterprise Value
38M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
674K
Total Assets
1.6M
Total Liabilities
674K
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -

Helix BioPharma Stock (OTC:HBPCF), Key Statistics

Helix BioPharma Stock (OTC: HBPCF) analysis, key statistics.

Valuation Measures
Enterprise Value
38M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
674K
Total Assets
1.6M
Total Liabilities
674K
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -

Helix BioPharma Stock (OTC:HBPCF), Key Statistics

Helix BioPharma Stock (OTC: HBPCF) analysis, key statistics.

Valuation Measures
Enterprise Value
38M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
674K
Total Assets
1.6M
Total Liabilities
674K
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -

Helix BioPharma Stock (OTC:HBPCF), Key Statistics

Helix BioPharma Stock (OTC: HBPCF) analysis, key statistics.

Valuation Measures
Enterprise Value
38M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
674K
Total Assets
1.6M
Total Liabilities
674K
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -

Helix BioPharma Stock (OTC:HBPCF), Key Statistics

Helix BioPharma Stock (OTC: HBPCF) analysis, key statistics.

Valuation Measures
Enterprise Value
38M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
674K
Total Assets
1.6M
Total Liabilities
674K
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -

Helix BioPharma Stock (OTC:HBPCF), Key Statistics

Helix BioPharma Stock (OTC: HBPCF) analysis, key statistics.

Valuation Measures
Enterprise Value
38M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
- -
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
674K
Total Assets
1.6M
Total Liabilities
674K
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -